Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients

Abstract The most widely used test for the diagnosis of SARS-CoV-2 infection is a PCR test. PCR has very high sensitivity and is able to detect very low amounts of RNA. However, many individuals receiving a positive test result in a context of a PCR-based surveillance might be infected with SARS-CoV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John G. Routsias, Maria Mavrouli, Panagiota Tsoplou, Kyriaki Dioikitopoulou, Athanasios Tsakris
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/29f51de075694e1f911e7d37cfea0b62
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:29f51de075694e1f911e7d37cfea0b62
record_format dspace
spelling oai:doaj.org-article:29f51de075694e1f911e7d37cfea0b622021-11-28T12:18:02ZDiagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients10.1038/s41598-021-02197-z2045-2322https://doaj.org/article/29f51de075694e1f911e7d37cfea0b622021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02197-zhttps://doaj.org/toc/2045-2322Abstract The most widely used test for the diagnosis of SARS-CoV-2 infection is a PCR test. PCR has very high sensitivity and is able to detect very low amounts of RNA. However, many individuals receiving a positive test result in a context of a PCR-based surveillance might be infected with SARS-CoV-2, but they are not contagious at the time of the test. The question arises regards if the cost effective, portable rapid antigen tests (RATs) have a better performance than PCR in identification of infectious individuals. In this direction, we examined the diagnostic performance of RATs from 14 different manufacturers in 400 clinical samples with known rRT-PCR cycles threshold (cT) and 50 control samples. Substantial variability was observed in the limit of detection (LOD) of different RATs (cT = 26.8–34.7). The fluorescence-based RAT exhibited a LOD of cT = 34.7. The use of the most effective RATs leads to true positive rates (sensitivities) of 99.1% and 90.9% for samples with cT ≤ 30 and cT ≤ 33, respectively, percentages that can guarantee a sensitivity high enough to identify contagious patients. RAT testing may also substantially reduce the quarantine period for infected individuals without compromising personal or public safety.John G. RoutsiasMaria MavrouliPanagiota TsoplouKyriaki DioikitopoulouAthanasios TsakrisNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
John G. Routsias
Maria Mavrouli
Panagiota Tsoplou
Kyriaki Dioikitopoulou
Athanasios Tsakris
Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients
description Abstract The most widely used test for the diagnosis of SARS-CoV-2 infection is a PCR test. PCR has very high sensitivity and is able to detect very low amounts of RNA. However, many individuals receiving a positive test result in a context of a PCR-based surveillance might be infected with SARS-CoV-2, but they are not contagious at the time of the test. The question arises regards if the cost effective, portable rapid antigen tests (RATs) have a better performance than PCR in identification of infectious individuals. In this direction, we examined the diagnostic performance of RATs from 14 different manufacturers in 400 clinical samples with known rRT-PCR cycles threshold (cT) and 50 control samples. Substantial variability was observed in the limit of detection (LOD) of different RATs (cT = 26.8–34.7). The fluorescence-based RAT exhibited a LOD of cT = 34.7. The use of the most effective RATs leads to true positive rates (sensitivities) of 99.1% and 90.9% for samples with cT ≤ 30 and cT ≤ 33, respectively, percentages that can guarantee a sensitivity high enough to identify contagious patients. RAT testing may also substantially reduce the quarantine period for infected individuals without compromising personal or public safety.
format article
author John G. Routsias
Maria Mavrouli
Panagiota Tsoplou
Kyriaki Dioikitopoulou
Athanasios Tsakris
author_facet John G. Routsias
Maria Mavrouli
Panagiota Tsoplou
Kyriaki Dioikitopoulou
Athanasios Tsakris
author_sort John G. Routsias
title Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients
title_short Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients
title_full Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients
title_fullStr Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients
title_full_unstemmed Diagnostic performance of rapid antigen tests (RATs) for SARS-CoV-2 and their efficacy in monitoring the infectiousness of COVID-19 patients
title_sort diagnostic performance of rapid antigen tests (rats) for sars-cov-2 and their efficacy in monitoring the infectiousness of covid-19 patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/29f51de075694e1f911e7d37cfea0b62
work_keys_str_mv AT johngroutsias diagnosticperformanceofrapidantigentestsratsforsarscov2andtheirefficacyinmonitoringtheinfectiousnessofcovid19patients
AT mariamavrouli diagnosticperformanceofrapidantigentestsratsforsarscov2andtheirefficacyinmonitoringtheinfectiousnessofcovid19patients
AT panagiotatsoplou diagnosticperformanceofrapidantigentestsratsforsarscov2andtheirefficacyinmonitoringtheinfectiousnessofcovid19patients
AT kyriakidioikitopoulou diagnosticperformanceofrapidantigentestsratsforsarscov2andtheirefficacyinmonitoringtheinfectiousnessofcovid19patients
AT athanasiostsakris diagnosticperformanceofrapidantigentestsratsforsarscov2andtheirefficacyinmonitoringtheinfectiousnessofcovid19patients
_version_ 1718408066369585152